Transforming

The Problem

The current standard of care is ineffective.

40M
SUFFERING
from Asthma and COPD in the US. 1 in 8 people are affected.
60%
UNCONTROLLED
60% of this population has symptoms that are uncontrolled.
$20B
SPEND
on ER visits and hospitalizations from Asthma and COPD.
Patients
Patients
Following the treatment plan requires daily self assessment of symptoms, and the patient has to choose the right medication and dosage accordingly.
The subjective assessment lacks compliance and often is error-prone, resulting in uncontrolled symptoms with frequent exacerbations.
Clinicians
No clear visibility on the patient's symptoms and patient's condition outside the standard clinical setting.
This makes it challenging to understand the level of control, effectiveness of the treatment plan, and any proactive interventions in the case of exacerbations.
Clinicians

Curie Solution

CurieAI delivers continuous, objective, and personalized respiratory care through advanced AI and connected devices.

Curie Solution
Objective Monitoring
Continuous, device-based assessment of symptoms and medication use.
Patient Mobile Application
Guidance on following treatment plan with active monitoring and patient engagement.
Patented Technology for Intelligent Health Monitoring
Transformative AI technology for passive continuous monitoring with NO patient effort or behavior change.
Pointer 1 Pointer 2 Pointer 3

Partner with Us

Adding more value to those working in value-based care

Providers
Providers
We provides a truly AI powered solution that will notify you when a patient needs your attention, making proactive interventions and significant cost savings a snap. Since no action is required from the patient, compliance is nearly 100%.
Hospitals
Healthcare Systems
We can help you better manage your chronic population, improve patient outcomes and minimize unnecessary readmissions and ER visits.
Payers
Payers
We understandproviders the risk of capitated fee agreements. Our easy to use tools allow you and your networks to understand who is at risk and how to intervene. This allows significant reduction in the total cost of care, including expensive ER visits and hospitalizations.

Our Team

Navya
Navya Davuluri
Founder, CEO
Sridhar
Sridhar Nemala
Co-Founder, Head of AI
Ravi
Ravi Yalamanchili
Co-Founder, Head of Engineering

Contact Us